News

Filter

Current filters:

Simbrinza

EMA/CHMP backs Alcon’s Simbrinza for glaucoma

25-05-2014

Swiss drug major Novartis’ eye care division Alcon says that the European Medicines Agency’s Committee…

AlconEuropeNovartisOphthalmicsPharmaceuticalRegulationSimbrinza

US FDA approves Alcon's Simbrinza, a fixed-combination therapy for glaucoma

22-04-2013

Swiss drug major Novartis' (NOVN: VX) eye care division Alcon on Friday (April 19) received US Food and…

AlconNorth AmericaNovartisOphthalmicsPharmaceuticalRegulationSimbrinza

Back to top